Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virus

Vaccine

Volumn 24, Issue 10, 2006, Pages 1530-1536

  Atrasheuskaya, A V ^a   Neverov, A A ^a   Rubin, S ^b   Ignatyev, G M ^a  

^a STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR   (Russian Federation)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Mumps vaccine virus transmission

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LIVE VACCINE; MUMPS VACCINE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; FEMALE; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUMPS; MUMPS VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE; SEROLOGY; SERUM; THROAT CULTURE; VACCINATION; VIRUS GENOME; VIRUS STRAIN; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; DISEASE TRANSMISSION, HORIZONTAL; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; MIDDLE AGED; MUMPS; MUMPS VACCINE; MUMPS VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VACCINATION; VIRUS SHEDDING;

EID: 32544447208     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.10.009     Document Type: Article

References (34)

1. World Health Organization. Mumps virus vaccines. Weekly Epidemiol Rec 2001;76:346-55.
2. S.S. da Cunha, L.C. Rorgigues, M.L. Barreto, and I. Dourado Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain Vaccine 20 2002 1106 1112
3. C.M. da Siveira, C.I. Kmetzsch, R. Mohrdieck, A.F. Sperb, and D.R. Prevots The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps rubella vaccine, Rio Grande do Sul, Brazil Int J Epidemiol 31 2002 975 982
4. W.J. Bakker, and R.G. Mathias Mumps caused by an inadequately attenuated measles, mumps and rubella vaccine Infect Dis Med Microbiol 12 2001 144 148
5. A.M. Galazka, S.E. Robertson, and A. Kraigher Mumps and mumps vaccine: a global review Bull World Health Organ 77 1999 3 12
6. N.V. Medynicin Vaccines used for prophylactic of epidemiological mumps in Russia Bull "Vaccination" 2003 1 2 10/08/2004 http://www.privivka.ru
7. O.A. Maksimova, V.F. Popov, T.A. Bektimirov, L.V. Grigoreva, T.N. Iunasova, and O.P. Kaplunova Comparative evaluation of neurovirulence of domestic and foreign live mumps vaccine Vopr Virusol 46 2001 31 35
8. M. Cizman, M. Mozetic, R. Radescek-Rakar, D. Pleterski-Rigler, and M. Susec-Mchieli Aseptic meningitis after vaccination against measles and mumps Pediatr Infect Dis J 8 1989 302 308
9. A. Tischer, and E. Gerike Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella Vaccine 18 2000 1382 1392
10. T. Nagai, and T. Nakayama Mumps vaccine virus genome is present in throat swabs obtained from uncomplicated healthy recipients Vaccine 19 2001 1353 1355
11. H. Sawada, S. Yano, Y. Oka, and T. Togashi Transmission of Urabe mumps vaccine between siblings Lancet 342 1993 71
12. M. Narita, Y. Matsuzono, Y. Takekoshi, S. Yamada, O. Itakura, and M. Kubota Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin G Clin Diagn Lab Immunol 5 1998 799 803
13. I. Davidkin, S. Jokinen, A. Paananen, P. Lejnikki, and H. Peltola Etiology of mumps-like illness in children and adolescents vaccinated for measles, mumps, and rubella J Infect Dis 191 2005 719 723
14. S.A. Rubin, G. Amexis, M. Pletnikov, Z. Li, J. Vanderzanden, and J. Mauldin Changes in mumps virus gene sequence associated with variability in neurovirulentphenotype J Virol 77 2003 13456 13464
15. W.A. Knowles, and J. Cohen Efficient isolation of mumps virus from a community outbreak using the marmoset lymphoblastoid cell line B95a J Virol Methods 96 2001 93 96
16. Yu.S. Boriskin, T.L. Kaptsova, V.D. Lotte, O.I. Skvortsova, and C. Orvell Laboratory markers for over-attenuation of mumps vaccine virus Vaccine 6 1988 483 488
17. A. Strohle, K. Eggenberger, C.A. Steiner, L. Matter, and D. Germann Mumps epidemic in vaccinated children in West Switzeland Schweiz Med Wochenschr 127 1997 1124 1133
18. J.P. Gut, C. Lablache, S. Behr, and A. Kim Symptomatic mumps virus reinfection J Med Virol 45 1995 17 23
19. C.P. Muller, S. Huiss, and F. Schneider Secondary immune responses in parents of children with recent measles Lancet 348 1996 1379 1380
20. S. Huiss, B. Damien, F. Schneider, and C.P. Muller Characteristics of asymptomatic secondary immune response to measles virus in late convalescent donors Clin Exp Immunol 109 1997 416 420
21. R.S. van Binnendijk, S. van den Hof, H. van den Kerkhof, R.H.G. Kohl, F. Woonink, and G.A.M. Berbers Evaluation of serological and virological tests in the diagnosis of clinical and subclinical measles virus infection during an outbreak of measles in the Nertherlands J Infect Dis 188 2003 898 903
22. G Ozanne, and M.A. D'Halewyn Secondary immune response in a vaccinated population during a large measles epidemic Clin Microbiol 30 1992 1778 1782
23. A. Santoshkumar Transmission of live vaccine viruses from vaccinated persons to others Indian Pediatr 7 2000 794 795
24. X. Huang, Y. Cao, and S. Tan Horizontal transmission of live attenuated hepatitis A vaccine virus Zhonghua Yi Xue Zhi 8 2001 465 467
25. F. Morfin, A. Beguin, B. Lina, and D. Thouvenot Detection of measles vaccine in the throat of vaccinated child Vaccine 20 2002 1541 1543
26. A. Tischer, and E. Gerike Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella Vaccine 18 2000 1382 1392
27. R.G. Pebody, N.J. Gay, L.M. Hesketh, A. Vyse, P. Morgan-Capner, and D.W. Brown Immunogenecity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance Vaccine 15 2002 1134 1140
28. P.J. Yates, M.A. Afzal, and P.D. Minor Antigenic and genetic variation of the NH protein of mumps virus strains J Gen Virol 77 1996 2491 2497
29. D.E. Griffin Immune response during measles virus infection Curr Top Microbiol Immunol 191 1995 117 134
30. I.G. Ovsyannikova, N. Dhiman, R.M. Jacobson, R.A. Vierkant, and G.A. Poland Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine Clin Diagn Lab Immunol 10 2003 411 416
31. B. Crowley, and M.A. Afzal Mumps virus reinfection - clinical findings and serological vagaries Commun Dis Public Health 5 2002 311 313
32. P.-L. Tan, R.M. Jacobson, G.A. Poland, S.J. Jacobsen, and V.S. Pankratz Twin studies of immunogenicity - determing the genetic contribution to vaccine failure Vaccine 19 2001 2434 2439
33. H.G. Kress, and H.W. Kreth HLA restriction of secondary mumps-specific cytotoxic T lymphocytes J Immunol 128 1982 844 849
34. WHO Expert Committee on Biological Standardization. Forty-third report. Geneva: World Health Organization; 1994 (WHO Technical Report Series No. 840).